Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis

World Journal of Gastroenterology

Volumn 23, Issue 7, 2017, Pages 1319-1324

  Günaltay, Sezin ^a   Rademacher, Lech ^b,c   Hörnquist, Elisabeth Hultgren ^a   Bohr, Johan ^a,b  

^a Örebro University   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c Avesta Hospital   (Sweden)

Author keywords

Collagenous colitis; Faecal microbiota transplantation; Flow cytometry; Lymphocytes; Microbiota

Indexed keywords

AZATHIOPRINE; BUDESONIDE; COLESTYRAMINE; DOXYCYCLINE; LOPERAMIDE; MESALAZINE;

AGED; ARTICLE; BURSITIS; CASE REPORT; COLLAGENOUS COLITIS; COLON BIOPSY; COLONOSCOPY; DIARRHEA; FATIGUE; FECAL MICROBIOTA TRANSPLANTATION; FECES INCONTINENCE; FECES MICROFLORA; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; LIVER TOXICITY; PEPTOCLOSTRIDIUM DIFFICILE; REMISSION; WEIGHT REDUCTION; BIOPSY; COLITIS, COLLAGENOUS; COLITIS, ULCERATIVE; CYTOLOGY; FECES; IMMUNOLOGY; LYMPHOCYTE; MICROBIOLOGY; MICROFLORA;

AGED; BIOPSY; COLITIS, COLLAGENOUS; COLITIS, ULCERATIVE; DIARRHEA; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTES; MICROBIOTA;

EID: 85014906903     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v23.i7.1319     Document Type: Article

References (30)

1. Nyhlin N, Wickbom A, Montgomery SM, Tysk C, Bohr J. Long-term prognosis of clinical symptoms and health-related quality of life in microscopic colitis: a case-control study. Aliment Pharmacol Ther 2014; 39: 963-972 [PMID: 24612051 DOI: 10.1111/apt.12685]
2. Langner C, Aust D, Ensari A, Villanacci V, Becheanu G, Miehlke S, Geboes K, Münch A. Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology 2015; 66: 613-626 [PMID: 25381724 DOI: 10.1111/his.12592]
3. Barmeyer C, Erko I, Fromm A, Bojarski C, Allers K, Moos V, Zeitz M, Fromm M, Schulzke JD. Ion transport and barrier function are disturbed in microscopic colitis. Ann N Y Acad Sci 2012; 1258: 143-148 [PMID: 22731727 DOI: 10.1111/j.1749-6632.2012.06631.x]
4. Münch A, Söderholm JD, Ost A, Ström M. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment. Am J Gastroenterol 2009; 104: 679-685 [PMID: 19209166 DOI: 10.1038/ajg.2008.95]
5. Taha Y, Carlson M, Thorn M, Loof L, Raab Y. Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis. Dig Dis Sci 2001; 46: 888-897 [PMID: 11330429]
6. Bohr J, Tysk C, Eriksson S, Abrahamsson H, Järnerot G. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996; 39: 846-851 [PMID: 9038667]
7. Bohr J, Wickbom A, Hegedus A, Nyhlin N, Hultgren Hörnquist E, Tysk C. Diagnosis and management of microscopic colitis: current perspectives. Clin Exp Gastroenterol 2014; 7: 273-284 [PMID: 25170275 DOI: 10.2147/CEG.S63905]
8. Pardi DS, Loftus EV, Tremaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mer-captopurine. Gastroenterology 2001; 120: 1483-1484 [PMID: 11313319]
9. Esteve M, Mahadevan U, Sainz E, Rodriguez E, Salas A, Fernández-Bañares F. Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohns Colitis 2011; 5: 612-618 [PMID: 22115383 DOI: 10.1016/j.crohns.2011.05.001]
10. Järnerot G, Tysk C, Bohr J, Eriksson S. Collagenous colitis and fecal stream diversion. Gastroenterology 1995; 109: 449-455 [PMID: 7615194]
11. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 2014; 8: 1569-1581 [PMID: 25223604 DOI: 10.1016/j.crohns.2014.08.006]
12. Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, Armstrong D, Marshall JK, Kassam Z, Reinisch W, Lee CH. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology 2015; 149: 102-109.e6 [PMID: 25857665 DOI: 10.1053/j.gastro.2015.04.001]
13. Rossen NG, MacDonald JK, de Vries EM, D'Haens GR, de Vos WM, Zoetendal EG, Ponsioen CY. Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. World J Gastroenterol 2015; 21: 5359-5371 [PMID: 25954111 DOI: 10.3748/wjg.v21.i17.5359]
14. Vermeire S, Joossens M, Verbeke K, Wang J, Machiels K, Sabino J, Ferrante M, Van Assche G, Rutgeerts P, Raes J. Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease. J Crohns Colitis 2016; 10: 387-394 [PMID: 26519463 DOI: 10.1093/ecco-jcc/jjv203]
15. Agrawal M, Aroniadis OC, Brandt LJ, Kelly C, Freeman S, Surawicz C, Broussard E, Stollman N, Giovanelli A, Smith B, Yen E, Trivedi A, Hubble L, Kao D, Borody T, Finlayson S, Ray A, Smith R. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals. J Clin Gastroenterol 2016; 50: 403-407 [PMID: 26352106 DOI: 10.1097/MCG.0000000000000410]
16. Girotra M, Garg S, Anand R, Song Y, Dutta SK. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes. Dig Dis Sci 2016; 61: 3007-3015 [PMID: 27447476 DOI: 10.1007/s10620-016-4229-8]
17. Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, Bakow B, Curran P, McKenney J, Tisch A, Reinert SE, Machan JT, Brandt LJ. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial. Ann Intern Med 2016; 165: 609-616 [PMID: 27547925 DOI: 10.7326/m16-0271]
18. Khoruts A, Rank KM, Newman KM, Viskocil K, Vaughn BP, Hamilton MJ, Sadowsky MJ. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Clin Gastroenterol Hepatol 2016; 14: 1433-1438 [PMID: 26905904 DOI: 10.1016/j.cgh.2016.02.018]
19. Carstens A, Dicksved J, Nelson R, Andreasson A, Bohr J, Tysk C, Agreus L, Engstrand L, Halfvarson J. Intestinal Dysbiosis in Collagenous Colitis. Gastroenterology 2015; 148: S-715
20. Fischer H, Holst E, Karlsson F, Benoni C, Toth E, Olesen M, Lindén M, Sjöberg K. Altered microbiota in microscopic colitis. Gut 2015; 64: 1185-1186 [PMID: 25841239 DOI: 10.1136/gutjnl-2014-308956]
21. Hjortswang H, Tysk C, Bohr J, Benoni C, Kilander A, Larsson L, Vigren L, Ström M. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis 2009; 15: 1875-1881 [PMID: 19504614 DOI: 10.1002/ibd.20977]
22. Kumawat AK, Strid H, Elgbratt K, Tysk C, Bohr J, Hultgren Hörnquist E. Microscopic colitis patients have increased proportions of Ki67(+) proliferating and CD45RO(+) active/memory CD8(+) and CD4(+)8(+) mucosal T cells. J Crohns Colitis 2013; 7: 694-705 [PMID: 22995775 DOI: 10.1016/j.crohns.2012.08.014]
23. Duranti S, Gaiani F, Mancabelli L, Milani C, Grandi A, Bolchi A, Santoni A, Lugli GA, Ferrario C, Mangifesta M, Viappiani A, Bertoni S, Vivo V, Serafini F, Barbaro MR, Fugazza A, Barbara G, Gioiosa L, Palanza P, Cantoni AM, de'Angelis GL, Barocelli E, de'Angelis N, van Sinderen D, Ventura M, Turroni F. Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers. FEMS Microbiol Ecol 2016; 92: pii: fiw191 [PMID: 27604252 DOI: 10.1093/femsec/fiw191]
24. Göranzon C, Kumawat AK, Hultgren-Hörnqvist E, Tysk C, Eriksson S, Bohr J, Nyhlin N. Immunohistochemical characterization of lymphocytes in microscopic colitis. J Crohns Colitis 2013; 7: e434-e442 [PMID: 23523417 DOI: 10.1016/j.crohns.2013.02.007]
25. Bohr J, Nordfelth R, Järnerot G, Tysk C. Yersinia species in collagenous colitis: a serologic study. Scand J Gastroenterol 2002; 37: 711-714 [PMID: 12126251]
26. Erim T, Alazmi WM, O'Loughlin CJ, Barkin JS. Collagenous colitis associated with Clostridium difficile: a cause effect? Dig Dis Sci 2003; 48: 1374-1375 [PMID: 12870798]
27. Epple HJ, Allers K, Tröger H, Kühl A, Erben U, Fromm M, Zeitz M, Loddenkemper C, Schulzke JD, Schneider T. Acute HIV infection induces mucosal infiltration with CD4+ and CD8+ T cells, epithelial apoptosis, and a mucosal barrier defect. Gastroenterology 2010; 139: 1289-1300 [PMID: 20600014 DOI: 10.1053/j.gastro.2010.06.065]
28. Poussier P, Ning T, Banerjee D, Julius M. A unique subset of self-specific intraintestinal T cells maintains gut integrity. J Exp Med 2002; 195: 1491-1497 [PMID: 12045247]
29. Karlsson M, Linton L, Lampinen M, Karlén P, Glise H, Befrits R, Janczewska I, Carlson M, Winqvist O, Eberhardson M. Naïve T cells correlate with mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol 2014; 49: 66-74 [PMID: 24188321 DOI: 10.3109/00365521.2013.853829]
30. Carrasco A, Esteve M, Salas A, Pedrosa E, Rosinach M, Aceituno M, Zabana Y, Fernández-Bañares F. Immunological Differences between Lymphocytic and Collagenous Colitis. J Crohns Colitis 2016; 10: 1055-1066 [PMID: 26928959 DOI: 10.1093/ecco-jcc/jjw058]